Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News InnoCan Pharma C.INNO

Alternate Symbol(s):  INNPF

Healthcare Drug Manufacturers - Specialty & Generic
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. The company's operations and research and development activities are based in Israel. Its business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: the research and development of CBD loaded exosomes; the research and development of the use of CBD loaded liposomes; and the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:INNO)

Fundamentals Snapshot (CSE:INNO)

Current News (CSE:INNO)

Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat

Canada NewsWire May 8, 2023

Innocan Pharma Announces 5000 Units Sale and Expansion to Lithuania, Latvia & Estonia Markets

Canada NewsWire May 1, 2023

Innocan Pharma Reports Annual 2022 Results with USD 2.6M in Revenue

Canada NewsWire April 18, 2023

Innocan Reports Novel Cannabinoid Delivery Platform Patent Application

Canada NewsWire April 3, 2023

Innocan Pharma (CSE:INNO) reports successful efficacy test for vaginal derma product

Maor Kagan March 23, 2023

Innocan Pharma Reports Successful Results of Efficacy Test for Vaginal Derma Product

Newsfile March 23, 2023

Innocan Pharma (CSE:INNO) to launch CBD veterinary commercialization team

Shoran Devi March 17, 2023

Innocan Pharma Announces Launch of CBD Veterinary Commercialization Team

Newsfile March 17, 2023

Ripples of Silicon Valley Bank's collapse felt at the TSX

Azuka Onwuka March 13, 2023
View More News ››

Opinion & Analysis (CSE:INNO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:INNO)

Innocan Pharma's Compassionate Care Treatment for Dogs

A Case Report Published in Frontiers in Veterinary Science Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 29, 2022) -...
Betteryear2 - April 29, 2022

Innocan Pharma's Case Report Accepted

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB...
Betteryear2 - April 11, 2022

Inauguration of Its Drug Development Lab

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB...
Betteryear2 - January 17, 2022

Why this Canadian-Israeli Stock Grew 121% This Year

"Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of...
dkeller85 - January 11, 2022

Distributers and investors

Our CEO Iris Bincovich reports back from Canada. She achieved: Meetings and soft commitments from distributers and investors and...
Charly50 - November 24, 2021

Successful Demonstration of Prolonged Release of CBD in Dogs

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:...
Betteryear2 - November 18, 2021
View more Bullboard ››

Saturn Oil & Gas Inc.

Saturn Oil & Gas Inc.

Saturn Oil & Gas Inc is a resource company engaged in the business of acquiring, exploration, and development of petroleum ...
View More »